SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation.

E3 SUMO ligases Ki-67 SUMOylation cell proliferation protein inhibitor of activated STAT (PIAS) protein modification quantitative proteomics topoisomerase 2A

Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
03 03 2023
Historique:
pubmed: 2 2 2023
medline: 7 3 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

Protein inhibitor of activated STAT (PIAS) proteins are E3 SUMO ligases playing important roles in protein stability and signaling transduction pathways. PIAS proteins are overexpressed in the triple-negative breast cancer cell line MDA-MB-231, and PIAS knockout (KO) results in a reduction in cell proliferation and cell arrest in the S phase. However, the molecular mechanisms underlying PIAS functions in cell proliferation and cell cycle remain largely unknown. Here, we used quantitative SUMO proteomics to explore the regulatory role of PIAS SUMO E3 ligases upon CRISPR/Cas9 KO of individual PIAS. A total of 1422 sites were identified, and around 10% of SUMO sites were regulated following KO of one or more PIAS genes. We identified protein substrates that were either specific to individual PIAS ligase or regulated by several PIAS ligases. Ki-67 and TOP2A, which are involved in cell proliferation and epithelial-to-mesenchymal transition, are SUMOylated at several lysine residues by all PIAS ligases, suggesting a level of redundancy between these proteins. Confocal microscopy and biochemical experiments revealed that SUMOylation regulated TOP2A protein stability, while this modification is involved in the recruitment of Ki-67 nucleolar proteins containing the SUMO interacting motif. These results provide novel insights into both the redundant and specific regulatory mechanisms of cell proliferation and cell cycle mediated by PIAS SUMO E3 ligases.

Identifiants

pubmed: 36723483
doi: 10.1021/acs.jproteome.2c00557
pmc: PMC9990128
doi:

Substances chimiques

Ki-67 Antigen 0
Ubiquitin-Protein Ligases EC 2.3.2.27
Small Ubiquitin-Related Modifier Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

812-825

Subventions

Organisme : CIHR
ID : PJT - 175093
Pays : Canada

Références

Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18739-44
pubmed: 17130457
Cell. 2010 Nov 24;143(5):848-848.e1
pubmed: 21111242
J Natl Cancer Inst. 2021 Nov 2;113(11):1595-1596
pubmed: 34003292
Methods Mol Biol. 2015;1295:455-63
pubmed: 25820740
Cell Mol Life Sci. 2003 Dec;60(12):2561-74
pubmed: 14685683
PLoS One. 2014 Feb 24;9(2):e89464
pubmed: 24586797
Nat Commun. 2015 Nov 30;6:8979
pubmed: 26616021
Oncogene. 2000 May 15;19(21):2638-44
pubmed: 10851063
J Biol Chem. 2020 May 8;295(19):6741-6753
pubmed: 32249212
DNA Repair (Amst). 2013 Sep;12(9):761-73
pubmed: 23871147
Aging (Albany NY). 2020 Nov 20;12(23):23836-23848
pubmed: 33221767
Nat Rev Mol Cell Biol. 2010 Dec;11(12):861-71
pubmed: 21102611
Cardiovasc Res. 2018 Mar 01;114(3):443-455
pubmed: 29206900
Cancer Res. 2017 Apr 1;77(7):1542-1547
pubmed: 28330929
Mol Cell Proteomics. 2018 May;17(5):871-888
pubmed: 29438996
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23588-23596
pubmed: 32900933
Int J Clin Exp Med. 2015 Jan 15;8(1):682-9
pubmed: 25785044
J Cell Sci. 2013 Sep 1;126(Pt 17):3939-47
pubmed: 23843607
Oncol Rep. 2004 Jun;11(6):1319-24
pubmed: 15138572
Dig Dis Sci. 2021 Sep;66(9):3074-3085
pubmed: 33040214
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Nucleic Acids Res. 2017 Jan 4;45(D1):D183-D189
pubmed: 27899595
Genes Dev. 2001 Dec 1;15(23):3088-103
pubmed: 11731474
Am J Pathol. 2012 May;180(5):2097-107
pubmed: 22449952
Nucleic Acids Res. 2015 Jan;43(2):848-61
pubmed: 25552417
Am J Cancer Res. 2017 Feb 01;7(2):370-382
pubmed: 28337384
J Proteome Res. 2012 Apr 6;11(4):2078-90
pubmed: 22316494
J Biol Chem. 2003 Aug 8;278(32):30091-7
pubmed: 12764129
PLoS One. 2015 Jun 19;10(6):e0129965
pubmed: 26090800
Proteomics. 2011 Jul;11(13):2654-71
pubmed: 21630457
Nat Commun. 2018 Jun 25;9(1):2456
pubmed: 29942033
J Immunol. 1984 Oct;133(4):1710-5
pubmed: 6206131
Mol Biol Cell. 2017 Jan 1;28(1):21-29
pubmed: 27807046
J Biol Chem. 2012 Jun 1;287(23):19599-609
pubmed: 22528486
Mol Biol Evol. 2016 Feb;33(2):568-84
pubmed: 26538142
Nat Commun. 2019 Sep 4;10(1):3987
pubmed: 31485003
Cell Death Dis. 2020 Apr 17;11(4):239
pubmed: 32303673
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W169-75
pubmed: 17576678
Front Mol Biosci. 2022 Apr 06;9:871161
pubmed: 35463961
Cell Cycle. 2015;14(12):1859-72
pubmed: 25895136
Cancer Res. 2007 Sep 1;67(17):8058-64
pubmed: 17804717
Br J Cancer. 2013 Oct 1;109(7):1795-804
pubmed: 24002598
Nat Commun. 2020 Feb 11;11(1):834
pubmed: 32047143
Cell Mol Life Sci. 2009 Sep;66(18):3029-41
pubmed: 19526197
Science. 1997 Dec 5;278(5344):1803-5
pubmed: 9388184
J Biol Chem. 2008 Jul 18;283(29):20137-48
pubmed: 18477566
FEBS J. 2020 Aug;287(15):3110-3140
pubmed: 32255256
J Cell Sci. 1996 Jun;109 ( Pt 6):1253-63
pubmed: 8799815
Database (Oxford). 2016 Dec 26;2016:
pubmed: 28025345
Nat Cell Biol. 2010 Nov;12(11):1078-85
pubmed: 20935639
Cell Rep. 2020 Oct 6;33(1):108251
pubmed: 33027645
PLoS Biol. 2019 Jun 21;17(6):e3000324
pubmed: 31226106
Dev Cell. 2013 Jan 14;24(1):1-12
pubmed: 23328396
Cell. 2001 Sep 21;106(6):735-44
pubmed: 11572779
Nat Rev Mol Cell Biol. 2021 Mar;22(3):165-182
pubmed: 32873929
J Vis Exp. 2018 Jan 29;(131):
pubmed: 29443041
Mod Pathol. 2001 Sep;14(9):886-91
pubmed: 11557785
Biol Res. 2017 May 25;50(1):19
pubmed: 28545522
BMC Biol. 2011 Aug 11;9:54
pubmed: 21834987
Mol Cancer. 2013 Sep 08;12(1):102
pubmed: 24010737
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10626-31
pubmed: 9724754
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5267-72
pubmed: 10805787
Cell Cycle. 2016 Dec;15(23):3151-3152
pubmed: 27484981
Int J Biol Markers. 2016 May 28;31(2):e204-10
pubmed: 26616229
Oncogene. 2001 Jun 28;20(29):3880-7
pubmed: 11439351
Nat Commun. 2017 Jan 18;8:14109
pubmed: 28098164
J Virol. 2013 May;87(10):5602-20
pubmed: 23468495
Nucleus. 2011 May-Jun;2(3):189-94
pubmed: 21818412
DNA Repair (Amst). 2020 Oct;94:102926
pubmed: 32674013
Blood. 2010 Apr 8;115(14):2827-34
pubmed: 19965618
Mol Oncol. 2019 May;13(5):1047-1058
pubmed: 30672125
Chromosoma. 2018 Jun;127(2):175-186
pubmed: 29322240
Cytoskeleton (Hoboken). 2015 Jul;72(7):305-39
pubmed: 26033929
Mol Syst Biol. 2020 Aug;16(8):e9469
pubmed: 32744794
J Biol Chem. 2010 Aug 13;285(33):25841-9
pubmed: 20562097

Auteurs

Chongyang Li (C)

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.

Alison Boutet (A)

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Molecular Biology program, Université de Montréal, Montréal, Québec H3C 3J7, Canada.

Cristina Mirela Pascariu (CM)

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.

Trent Nelson (T)

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Molecular Biology program, Université de Montréal, Montréal, Québec H3C 3J7, Canada.

Mathieu Courcelles (M)

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.

Zhaoguan Wu (Z)

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Department of Chemistry, Université de Montréal, Montréal, Québec H3C 3J7, Canada.

Simon Comtois-Marotte (S)

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.

Gregory Emery (G)

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Department of Pathology and Cell Biology, Université de Montréal, Montréal, Québec H3C 3J7, Canada.

Pierre Thibault (P)

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Molecular Biology program, Université de Montréal, Montréal, Québec H3C 3J7, Canada.
Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec H3C 3J7, Canada.

Articles similaires

Killer Cells, Natural Animals Colorectal Neoplasms Decorin Adenoviridae

A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.

Lisa Demoen, Filip Matthijssens, Lindy Reunes et al.
1.00
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Animals Mice Humans Cell Line, Tumor
Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition

Classifications MeSH